SRPK1 inhibition suppresses angiogenesis, metastasis, and the acquisition of a cancer stem cell phenotype, enhancing apoptosis in lung cancer [187, 188] and reducing the survival of cancer cells [189]. The gene discussed is SRPK1; the disease is lung cancer.